614 related articles for article (PubMed ID: 19171434)
1. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
Shi M; Guo N
Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA involvement in the pathogenesis and management of breast cancer.
Khoshnaw SM; Green AR; Powe DG; Ellis IO
J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in breast cancer pathogenesis.
Götte M
Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
[TBL] [Abstract][Full Text] [Related]
4. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis.
Shi M; Liu D; Duan H; Shen B; Guo N
Cancer Metastasis Rev; 2010 Dec; 29(4):785-99. PubMed ID: 20938719
[TBL] [Abstract][Full Text] [Related]
5. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
[TBL] [Abstract][Full Text] [Related]
6. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.
Lowery AJ; Miller N; McNeill RE; Kerin MJ
Clin Cancer Res; 2008 Jan; 14(2):360-5. PubMed ID: 18223209
[TBL] [Abstract][Full Text] [Related]
8. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
11. [What is new in the biology and prognosis of breast cancer?].
Kosma VM
Duodecim; 2005; 121(24):2621-2. PubMed ID: 16454244
[No Abstract] [Full Text] [Related]
12. New molecular classifications of breast cancer.
Cianfrocca M; Gradishar W
CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
[TBL] [Abstract][Full Text] [Related]
13. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS
Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
Iorio MV; Casalini P; Tagliabue E; Ménard S; Croce CM
Eur J Cancer; 2008 Dec; 44(18):2753-9. PubMed ID: 19022662
[TBL] [Abstract][Full Text] [Related]
15. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
[TBL] [Abstract][Full Text] [Related]
16. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA.
Liang Z; Wu H; Reddy S; Zhu A; Wang S; Blevins D; Yoon Y; Zhang Y; Shim H
Biochem Biophys Res Commun; 2007 Nov; 363(3):542-6. PubMed ID: 17889832
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA function in cancer: oncogene or a tumor suppressor?
Shenouda SK; Alahari SK
Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil drug alters the microRNA expression profiles in MCF-7 breast cancer cells.
Shah MY; Pan X; Fix LN; Farwell MA; Zhang B
J Cell Physiol; 2011 Jul; 226(7):1868-78. PubMed ID: 21506117
[TBL] [Abstract][Full Text] [Related]
20. The roles of microRNA in cancer and apoptosis.
Lynam-Lennon N; Maher SG; Reynolds JV
Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
